AlJohani NI. Remission frequency versus remission quality in transplant-eligible older patients. Comment on: “Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy versus liposomal cytarabine and daunorubicin”. haematol [Internet]. 2020Sep.10 [cited 2026Jul.26];. Available from: https://haematologica.org/article/view/14294